18. Patent Battles and Commercialization

As CRISPR’s commercial value soared, intense patent disputes erupted between leading research institutions over ownership of the technology. These legal battles have significant implications for biotech startups, licensing agreements, and the pace of innovation. The outcome shapes who can develop and market CRISPR-based products, influencing research funding and access to cutting-edge therapies worldwide. [Source: STAT News]